Herpes Encephalitis: A Mortal Complication in a Patient Treated with Immunosuppressive Drugs because of Immune-Related Adverse Events after Ipilimumab Treatment.

about

Herpes Encephalitis: A Mortal Complication in a Patient Treated with Immunosuppressive Drugs because of Immune-Related Adverse Events after Ipilimumab Treatment.

Item

http://www.wikidata.org/entity/Q50073542

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Herpes Encephalitis: A Mortal ...... ts after Ipilimumab Treatment.

@en

Herpes Encephalitis: A Mortal ...... ts after Ipilimumab Treatment.

@nl

type

Item

label

Herpes Encephalitis: A Mortal ...... ts after Ipilimumab Treatment.

@en

Herpes Encephalitis: A Mortal ...... ts after Ipilimumab Treatment.

@nl

prefLabel

Herpes Encephalitis: A Mortal ...... ts after Ipilimumab Treatment.

@en

Herpes Encephalitis: A Mortal ...... ts after Ipilimumab Treatment.

@nl

P1476

Herpes Encephalitis: A Mortal ...... ts after Ipilimumab Treatment.

@en

P2093

Caroline M Loos

http://www.w3.org/2001/XMLSchema#string

Lieke van Montfort

http://www.w3.org/2001/XMLSchema#string

Monique Anten

http://www.w3.org/2001/XMLSchema#string

Rob L H Jansen

http://www.w3.org/2001/XMLSchema#string

P2860

Immune Checkpoint Blockade in Cancer Therapy

Systematic review and network meta-analysis of overall survival comparing 3 mg/kg ipilimumab with alternative therapies in the management of pretreated patients with unresectable stage III or IV melanoma

Herpes simplex virus encephalitis during treatment with etanercept.

Pooled Analysis of Long-Term Survival Data From Phase II and Phase III Trials of Ipilimumab in Unresectable or Metastatic Melanoma

Herpes simplex encephalitis during treatment with tumor necrosis factor-alpha inhibitors.

Cross-regulation between herpesviruses and the TNF superfamily members

Tumor necrosis factor (TNF) protects resistant C57BL/6 mice against herpes simplex virus-induced encephalitis independently of signaling via TNF receptor 1 or 2.

Acyclovir-resistant herpes simplex encephalitis in a patient treated with anti-tumor necrosis factor-α monoclonal antibodies.

P304

1112-1115

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.1159/000484553

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29430235

http://www.w3.org/2001/XMLSchema#string

P932

5803703

http://www.w3.org/2001/XMLSchema#string